$ Orphazyme A/S (ORPH)$ Share prices are rising drastically in Copenhagen, which means that the drug arimoclomol must have been approved or it’s an indication of a good thing that has happened to the company, I would recommend a buy rating looking at the current statistics and price value in US which is around 14-15 currently as it’s bound to shoot up in tonight’s market!!